DK302190A - Fremgangsmaade til behandling af neurologiske tilstande - Google Patents
Fremgangsmaade til behandling af neurologiske tilstande Download PDFInfo
- Publication number
- DK302190A DK302190A DK302190A DK302190A DK302190A DK 302190 A DK302190 A DK 302190A DK 302190 A DK302190 A DK 302190A DK 302190 A DK302190 A DK 302190A DK 302190 A DK302190 A DK 302190A
- Authority
- DK
- Denmark
- Prior art keywords
- neurological conditions
- treating neurological
- chem
- compositions
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/223,739 US4973586A (en) | 1986-01-16 | 1988-07-18 | Fused benzazepines, compositions of, and medical use thereof |
PCT/US1989/002997 WO1990000853A2 (en) | 1988-07-18 | 1989-07-14 | Method of treating neurological disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
DK302190D0 DK302190D0 (da) | 1990-12-20 |
DK302190A true DK302190A (da) | 1991-01-11 |
Family
ID=22837795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK302190A DK302190A (da) | 1988-07-18 | 1990-12-20 | Fremgangsmaade til behandling af neurologiske tilstande |
Country Status (13)
Country | Link |
---|---|
US (1) | US4973586A (da) |
EP (2) | EP0351733B1 (da) |
JP (1) | JPH0662420B2 (da) |
KR (1) | KR900701275A (da) |
AT (1) | ATE131056T1 (da) |
AU (1) | AU634973B2 (da) |
CA (1) | CA1336823C (da) |
DE (1) | DE68925004T2 (da) |
DK (1) | DK302190A (da) |
ES (1) | ES2080736T3 (da) |
IL (1) | IL90973A (da) |
WO (1) | WO1990000853A2 (da) |
ZA (1) | ZA895343B (da) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5302716A (en) * | 1986-01-16 | 1994-04-12 | Schering Corporation | Fused benzazepines |
US5091526A (en) * | 1988-07-29 | 1992-02-25 | Schering Corporation | Process for the enantiospecific synthesis of intermediates for hexahydro-benzo[d]-naphtho[2,1-b]azepines |
CA2016465A1 (en) * | 1989-06-02 | 1990-12-02 | Zola Phillip Horovitz | Method for preventing or treating anxiety employing a calcium channel blocker |
ES2075429T3 (es) * | 1990-02-02 | 1995-10-01 | Schering Corp | Derivados de 4,5-cicloalcano-3-benzazepin-7-ol y sus usos. |
US5312819A (en) * | 1990-08-20 | 1994-05-17 | Sandoz Ltd. | Pharmaceutical compositions comprising clozapine and a radical scavenger |
US5461148A (en) * | 1993-09-27 | 1995-10-24 | Schering Corporation | Process for preparing benzazepine intermediates for the synthesis of D1 antagonists |
US5463051A (en) * | 1993-09-27 | 1995-10-31 | Schering Corporation | Process for preparing benzazepine intermediates for the synthesis of D1 antagonists |
US5461147A (en) * | 1993-09-27 | 1995-10-24 | Schering Corporation | Process for preparing benzazepine intermediates for the synthesis of D1 antagonists |
CA2304592A1 (en) * | 1997-09-24 | 1999-04-01 | The General Hospital Corporation | Inhibition of psychostimulant-induced and nicotine-induced craving |
US6410527B1 (en) | 1998-03-02 | 2002-06-25 | Schering Corporation | Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism |
US6875866B2 (en) * | 2002-02-21 | 2005-04-05 | Schering Corporation | Process for synthesis of D1 receptor antagonists |
DE60321354D1 (de) * | 2002-08-29 | 2008-07-10 | Schering Corp | Selektive d1/d5 rezeptorantagonisten zur behandlung von fettleibigkeit und von zns störungen |
JP2006526021A (ja) * | 2003-05-22 | 2006-11-16 | シェーリング コーポレイション | 肥満およびcns障害を治療する選択的d1/d5レセプタアンタゴニストとしての5h−ベンゾ[d]ナフト[2,1−b]アゼピン誘導体 |
ES2914043T3 (es) | 2012-07-12 | 2022-06-07 | Emalex Biosciences Inc | Benzazepinas condensadas para el tratamiento del síndrome de tourette |
SI3057595T1 (sl) | 2013-10-18 | 2020-09-30 | Emalex Biosciences, Inc. | Spojeni benzazepini za zdravljenje jecljanja |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3393192A (en) * | 1965-04-26 | 1968-07-16 | Schering Corp | Novel benzazepines |
CH481110A (de) * | 1967-02-17 | 1969-11-15 | Geigy Ag J R | Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen |
GB1118688A (en) * | 1967-02-17 | 1968-07-03 | Scherico Ltd | Novel benzazepines and process for making same |
US3609138A (en) * | 1967-12-22 | 1971-09-28 | Ciba Geigy Corp | 1-aryl-3-benzazepines |
IL39381A0 (en) * | 1971-05-10 | 1972-07-26 | Sparamedica Ag | Rheadan-type alkaloids,their preparation and pharmaceutical compositions containing them |
US3983234A (en) * | 1974-07-04 | 1976-09-28 | Sandoz Ltd. | Treatment of dyskinesias |
US3939165A (en) * | 1974-11-14 | 1976-02-17 | Morton-Norwich Products, Inc. | 5,6,6A,6B,7,8-Hexahydrobenz[a]phenanthridine hydrochloride |
US4011319A (en) * | 1975-07-02 | 1977-03-08 | Smithkline Corporation | Pharmaceutical compositions and methods involving benzazepine derivatives |
US4284555A (en) * | 1979-04-27 | 1981-08-18 | Schering Corporation | 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
US4315926A (en) * | 1979-12-26 | 1982-02-16 | Ciba-Geigy Corporation | Dibenz[c,e]azepines |
US4477378A (en) * | 1980-02-05 | 1984-10-16 | Schering Corp. | Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
DE3007710C2 (de) * | 1980-02-29 | 1982-04-15 | Gödecke AG, 1000 Berlin | 5,6;8,9-Tetrahydro-7H-dibenz(d,f)azonin-derivate, Verfahren zu deren Herstellung und Arzneimittel |
JPH0681745B2 (ja) | 1986-01-16 | 1994-10-19 | シェリング・コ−ポレ−ション | 縮合ベンゾアゼピン |
ATE78467T1 (de) * | 1987-07-15 | 1992-08-15 | Schering Corp | Kondensierte benzazepine. |
-
1988
- 1988-07-18 US US07/223,739 patent/US4973586A/en not_active Expired - Lifetime
-
1989
- 1989-07-13 ZA ZA895343A patent/ZA895343B/xx unknown
- 1989-07-14 EP EP89112959A patent/EP0351733B1/en not_active Expired - Lifetime
- 1989-07-14 WO PCT/US1989/002997 patent/WO1990000853A2/en active Search and Examination
- 1989-07-14 ES ES89112959T patent/ES2080736T3/es not_active Expired - Lifetime
- 1989-07-14 CA CA000605690A patent/CA1336823C/en not_active Expired - Fee Related
- 1989-07-14 IL IL9097389A patent/IL90973A/en not_active IP Right Cessation
- 1989-07-14 AU AU39884/89A patent/AU634973B2/en not_active Ceased
- 1989-07-14 JP JP1508220A patent/JPH0662420B2/ja not_active Expired - Fee Related
- 1989-07-14 EP EP89908786A patent/EP0434695A1/en active Pending
- 1989-07-14 AT AT89112959T patent/ATE131056T1/de not_active IP Right Cessation
- 1989-07-14 DE DE68925004T patent/DE68925004T2/de not_active Expired - Fee Related
-
1990
- 1990-03-16 KR KR1019900700564A patent/KR900701275A/ko not_active Application Discontinuation
- 1990-12-20 DK DK302190A patent/DK302190A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE131056T1 (de) | 1995-12-15 |
KR900701275A (ko) | 1990-12-01 |
ES2080736T3 (es) | 1996-02-16 |
EP0351733B1 (en) | 1995-12-06 |
AU3988489A (en) | 1990-02-19 |
DK302190D0 (da) | 1990-12-20 |
EP0434695A1 (en) | 1991-07-03 |
JPH03502100A (ja) | 1991-05-16 |
EP0351733A1 (en) | 1990-01-24 |
DE68925004T2 (de) | 1996-05-15 |
JPH0662420B2 (ja) | 1994-08-17 |
AU634973B2 (en) | 1993-03-11 |
WO1990000853A8 (en) | 2005-06-16 |
US4973586A (en) | 1990-11-27 |
DE68925004D1 (de) | 1996-01-18 |
WO1990000853A2 (en) | 1990-02-08 |
CA1336823C (en) | 1995-08-29 |
ZA895343B (en) | 1991-03-27 |
IL90973A (en) | 1994-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK302190D0 (da) | Fremgangsmaade til behandling af neurologiske tilstande | |
IL90102A0 (en) | Fused polycyclic compounds,method of manufacture,and their use as paf antagonists,antihistamines and/or antiinflammatory agents | |
FI931370A (fi) | Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring | |
DE68927697D1 (de) | Fluor substituierte Benzocycloheptapyridine, Zusammensetzungen und Verfahren zur Verwendung derselben als antihistaminische Verbindungen | |
DK0556332T3 (da) | Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet | |
FI100240B (fi) | Menetelmä keskushermostoon vaikuttavien substituoitujen syklohekseenie n valmistamiseksi | |
ES2070934T3 (es) | Derivados de oxotremorina 3- o 4-sustituidos. | |
DE69121032D1 (de) | Verfahren zur Granulation von 2,2,6,6-tetramethylpiperidin-enthaltendem Lichtstabilisator | |
DK0430035T3 (da) | Anvendelse af benzothiazepiner til fremstilling af lægemidler til behandling af epileptiske anfald | |
DK9390D0 (da) | Kondenserede benzapiner | |
FI870994A0 (fi) | Foerfarande foer framstaellning av stabila, injekterbara farmaceutiska kompositioner, vilka innehaoller 1,4-dihydroxi-5,8-bis/2-(2-hydroxietylamino)etylamino/ antrakinondihydroklorid. | |
DE69015411D1 (de) | 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS. | |
DK0384498T3 (da) | Farmaceutisk præparat til inducering af dannelse af cytokiner | |
ATE158293T1 (de) | Polycyclische 31668p- und 31668u-verbindungen, verfahren zu ihrer herstellung und ihre verwendung als antibiotische oder antitumorale arzneistoffe | |
DK0412941T3 (da) | Phospholipider til behandling af dissemineret sklerose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |